| Literature DB >> 29034193 |
Hassan Fahmi Ismail1, Zanariah Hashim1, Wong Tet Soon1, Nur Syukriah Ab Rahman2, Ain Nabihah Zainudin2, Fadzilah Adibah Abdul Majid2.
Abstract
Natural antioxidants derived from plants have shown a tremendous inhibitory effect on free radicals in actively metabolizing cells. Overproduction of free radicals increases the risk factor of chronic diseases associated with diabetes, cancer, arthritis and cardiovascular disease. Andrographis paniculata, Cinnamon zeylanicum, Curcuma xanthorrhiza, Eugenia polyantha and Orthosiphon stamineus are ethnomedicinal plants used in the Asian region to treat various illnesses from a common fever to metabolic disease. In this study, we have quantified the total phenolic (TPC) and flavonoid content (TFC) in these plants and its inhibitory effect on 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) and 2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) free radicals as well as the cytotoxicity effect on cell lines proliferation and zebrafish embryogenesis. Results showed that Cinnamon zeylanicum and E. polyantha have the highest phenolic and flavonoid content. Furthermore, both herbs significantly inhibited the formation of DPPH and ABTS free radicals. Meanwhile, O. stamineus exhibited minimum cytotoxicity and embryotoxicity on tested models. Good correlation between IC50 of 3T3-L1 cells and LC50 embyrotoxicity was also found. This study revealed the potent activity of antioxidant against free radical and the toxicology levels of the tested herbal plants.Entities:
Keywords: Antioxidant; Cytotoxicity; Embryotoxicity; Herbal; Total phenolic content
Year: 2017 PMID: 29034193 PMCID: PMC5634737 DOI: 10.1016/j.jtcme.2016.12.006
Source DB: PubMed Journal: J Tradit Complement Med ISSN: 2225-4110
Fig. 1FTIR spectra (4000 cm−1 to 370 cm−1) of Andrographis paniculata (AP), Cinnamon zeylanicum (CZ), Curcuma xanthorrhiza (CX), Eugenia polyantha (EP) and Orthosiphon stamineus (OS) water extracts. Similar transmission trends were detected in all extracts.
List of chemical functional groups present in AP, CX, CZ, EP and OS.
| Functional group | Vibration (Stretch/Bend) | Range | AP | CX | CZ | EP | OS |
|---|---|---|---|---|---|---|---|
| Alkanes | C–H stretch | 3000–2800 | ✓ | ✓ | ✓ | ✓ | ✓ |
| C–H bend | 1500–1440 | – | – | ✓ | ✓ | – | |
| Alkenes | C–H stretch | 3200–3000 | – | – | – | – | – |
| C | 1680–1600 | ✓ | ✓ | ✓ | ✓ | ✓ | |
| Aromatic rings | (sp2) = C–H stretch | 3200–3000 | – | – | – | – | – |
| C | 1600–1400 | ✓ | ✓ | ✓ | |||
| Hydroxyl compounds | O–H stretch | 3600–3200 | |||||
| Carbonyl compounds | C | 1610–1550 | ✓ | – | – | – | – |
| Amino acid | C | 1600–1660 | ✓ | ✓ | ✓ | ✓ | ✓ |
| Aldehydes | C | 1750–1625 | – | – | – | ✓ | |
| C–H stretch of C | 2700–2850 | – | – | – | – | – | |
| Amines | N–H stretch | 3500–3100 | ✓ | ✓ | ✓ | ✓ | ✓ |
| N–H Bend | 1640–1550 | ✓ | ✓ | ✓ | ✓ | ✓ | |
| Nitriles | C | 2500–2000 | ✓ | ✓ | ✓ | – | ✓ |
| Amides | N–H stretch | 3500–3100 | ✓ | ✓ | ✓ | ✓ | ✓ |
| C | 1670–1600 | ✓ | ✓ | ✓ | ✓ | ✓ | |
| N–H bend | 1640–1550 | ✓ | ✓ | ✓ | ✓ | ✓ | |
| Ethers | C–O stretch | 1040 & 1260 | ✓ | ✓ | – | – | ✓ |
List of five major compounds, chromatogram percentage area, height, retention time and biological activity of AP, CX, CZ, EP and OS detected by GC–MS.
| Herb | Compound | Area% | Height% | Retention time | Biological Activity |
|---|---|---|---|---|---|
| AP | Octadecanoic acid methyl ester | 22.27 | 27.95 | 36.809 | Anti-viral, anti-microbial |
| 1,2-Cyclopentanedione | 8.50 | 12.79 | 6.863 | NA | |
| Octadecanoic acid, 2,3-dihydroxypropyl ester | 6.82 | 4.90 | 46.755 | Co-solvents, oil carrier, antioxidant, anti-acne | |
| n-Undecane | 6.47 | 4.70 | 11.827 | NA | |
| Tetraacetyl-d-xylonic nitrile | 3.97 | 1.98 | 25.861 | Antioxidant, anti-cancer | |
| CX | Octadecanoic acid, methyl ester | 19.56 | 20.78 | 36.798 | Anti-viral, anti-microbial |
| Xanthorrhizol | 18.12 | 19.29 | 29.201 | Antioxidant, anti-microbial, anti-inflammatory, anti-hyperglycemic, nephroprotective and hepatoprotective | |
| Benzene, 1-(1,5-dimethyl-4-hexenyl)-4-methyl- | 6.43 | 7.37 | 22.690 | Antioxidant, anti-viral, anti-ulcer | |
| 4-vinylquaiacol | 4.62 | 5.08 | 18.069 | Antioxidant, anti-inflammatory | |
| beta.-Elemenone | 4.39 | 4.51 | 25.716 | NA | |
| CZ | Coumarin | 21.14 | 21.93 | 21.505 | Anti-inflammatory, anti-coagulant, antibacterial, anti-fungal, anti-viral, – anti-hypertensive, anti-tubercular, anti-convulsant, anti-obesity, anti-hyperglycemic, anti-oxidant, and neuroprotective, anti-tumor, anti-HIV agents, CNS-active compounds |
| Octadecanoic acid, methyl ester | 14.92 | 17.64 | 36.797 | Anti-viral, anti-microbial | |
| n-Undecane | 5.16 | 3.35 | 11.824 | NA | |
| Cinnamaldehyde | 4.20 | 4.64 | 16.889 | Anti-microbial, anti-inflammatory, anti-arthritis, anti-cancer, anti-oxidant, anti-hyperglycemic, anti-obesity, neuroprotective, | |
| Formic acid, 2-propenyl ester | 3.26 | 2.46 | 8.471 | NA | |
| EP | Octadecanoic acid, methyl ester | 22.09 | 15.67 | 36.734 | An-tiviral, anti-microbial |
| Coumarin | 20.56 | 14.56 | 21.515 | Anti-inflammatory, anti-coagulant, antibacterial, anti-fungal, anti-viral, – anti-hypertensive, anti-tubercular, anti-convulsant, anti-obesity, anti-hyperglycemic, anti-oxidant, and neuroprotective, anti-tumor, anti-HIV agents, CNS-active compounds | |
| Octadecanoic acid, 2,3-dihydroxypropyl ester | 7.23 | 6.43 | 46.697 | Co-solvents, oil carrier, antioxidant, anti-acne | |
| Eugenol | 3.87 | 3.21 | 4.562 | Anti-cancer, antioxidant, anti-mutagenic, anti-genotoxic, anti-inflammatory | |
| n-Undecane | 3.55 | 2.45 | 11.854 | NA | |
| OS | Octadecanoic acid, methyl ester | 11.08 | 15.95 | 36.811 | Anti-viral, anti-microbial |
| 2-hydroxy-4-methylbenzaldehyde | 8.27 | 8.36 | 21.922 | NA | |
| Butyrate, 3-methyl-, 3-butenyl-3-methyl- | 7.37 | 7.76 | 11.833 | NA | |
| Octadecanoic acid, 2,3-dihydroxypropyl ester | 7.33 | 4.60 | 46.760 | Antioxidant, anti-acne | |
| Coumarin | 7.22 | 2.75 | 21.512 | Anti-inflammatory, anti-coagulant, anti-bacterial, anti-fungal, anti-viral, – anti-hypertensive, anti-tubercular, anti-convulsant, anti-obesity, anti-hyperglycemic, anti-oxidant, and neuroprotective, anti-tumor, anti-HIV agents, CNS-active compounds |
NA− Not available.
Amount of selected biomarkers in AP (andrographolide), CX (curcumin), CZ (catechin), EP (gallic acid) and OS (rosmarinic acid) quantified by HPLC fingerprinting.
| Biomarkers | Andrographolide (μg/mg) | Curcumin (μg/mg) | Catechin (μg/mg) | Gallic acid (μg/mg) | Rosmarinic acid (μg/mg) |
|---|---|---|---|---|---|
| AP | 17.78 | – | – | – | – |
| CX | – | 4.65 | – | – | – |
| CZ | – | – | 4.29 | – | – |
| EP | – | – | – | 12.08 | – |
| OS | – | – | – | – | 6.39 |
Mean of TPC, TFC and EC50 of DPPH and ABTS radical scavenging activity.
| Herbs | Total phenolic content (mg GAE/100 g sample) | Total flavonoid content (mg CE/100 g sample) | EC50 – DPPH RSA (μg/ml) | EC50 – ABTS RSA (μg/ml) |
|---|---|---|---|---|
| AP | 21.2 ± 1.345 | 24.5 ± 0.741 | 143.7 | 915.0 |
| CX | 20.1 ± 0.712 | 21.1 ± 0.217 | 326.3 | 1076.0 |
| CZ | 269.9 ± 28.6 | 62.1 ± 3.064 | 11.03 | 78.26 |
| EP | 219.4 ± 9.586 | 20.3 ± 0.512 | 15.48 | 94.27 |
| OS | 94.9 ± 0.310 | 29.3 ± 1.271 | 53.51 | 284.9 |
| Ascorbic acid | – | – | 2.563 | 34.58 |
Each value in the table is represented as mean (n = 3).
Fig. 2Antioxidant activities of AP, CX, CZ, EP and OS at various concentrations ranging from 5 to 5000 μg/ml. a) DPPH radical scavenging activities. b) ABTS radical scavenging. Ascorbic acid was used as a standard. Results were expressed in mean ± SEM (n = 3).
Correlation coefficient (R2) between TPC and TFC against antioxidant activities. Positive correlations were determined for all extracts.
| Herbs | TPC | TFC | ||
|---|---|---|---|---|
| DPPH | ABTS | DPPH | ABTS | |
| AP | 0.8441** | 0.6859*** | 0.8391**** | 0.6786*** |
| CX | 0.8012**** | 0.6546** | 0.7990**** | 0.6524** |
| CZ | 0.8227**** | 0.7545*** | 0.8030**** | 0.8068**** |
| EP | 0.7756*** | 0.7448*** | 0.7308*** | 0.8300**** |
| OS | 0.7850**** | 0.7372*** | 0.8043**** | 0.7930*** |
** Significant at p < 0.01.
*** Significant at p < 0.001.
**** Significant at p < 0.0001.
Fig. 31.1B4 cell proliferation during AP, CX, CZ, EP and OS treatment for 24 h. Different levels of cytotoxicity effect were identified in each herb. Significant decrease (p < 0.05) in viability was observed starting from 0.5 mg/ml for AP (Fig. 3A) and EP (Fig. 3D), 1.0 mg/ml for CZ (Fig. 3C) and 5.0 mg/ml for CX (Fig. 3B) and OS (Fig. 3E). AP and EP, 500 μg/ml for CZ and 1000 μg/ml for CX and OS.
Fig. 43T3-L1 cell proliferation during AP, CX. CZ, EP and OS treatment for 24 h. Significant decrease (p < 0.05) in viability was observed starting from 0.5 mg/ml for AP (Fig. 4A), CZ (Fig. 4C) and EP (Fig. 4D) and 5.0 mg/ml for CX (Fig. 4B) and OS (Fig. 4E).
Fig. 5WRL-68 cell proliferation during AP, CX. CZ, EP and OS treatment for 24 h. Significant decrease (p < 0.05) in viability was observed starting from 0.5 mg/ml for AP (Fig. 5A), 1.0 mg/ml for CZ (Fig. 5C), EP (Fig. 5D) and OS (Fig. 5E). CX (Fig. 5B) was shown to inhibit cell proliferation at 5.0 mg/ml.
IC50 of extracts that cause 50% inhibition on 1.1B4, 3T3-L1 and WRL-68 cell viability.
| Herbs | 1.1B4 (mg/ml) | 3T3-L1 (mg/ml) | WRL-68 (mg/ml) |
|---|---|---|---|
| AP | 2.345 | 0.6498 | 0.440 |
| CX | 3.099 | 3.786 | 3.406 |
| CZ | 4.692 | 3.928 | 3.681 |
| EP | 0.365 | 2.430 | 2.213 |
| OS | 9.934 | 6.335 | 4.014 |
Fig. 6Mortality and survival curves of 96 hpf zebrafish embryos during AP, CX. CZ, EP and OS treatment. At a concentration of 0.05 mg/ml, CZ (Fig. 6C) and EP (Fig. 6D) caused significant mortality. Meanwhile, AP (Fig. 6A) and CX (Fig. 6B) caused mortality at 0.5 mg/ml and OS (Fig. 6E) at 5 mg/ml.
LC50 of extracts at 48 hpf and 96 hpf of FET test.
| Herbs | LC50-48 hpf (mg/ml) | LC50-96 hpf (mg/ml) |
|---|---|---|
| AP | 0.5255 | 0.5256 |
| CX | 0.7486 | 0.7037 |
| CZ | 0.9858 | 0.05058 |
| EP | 0.9212 | 0.06039 |
| OS | 1.685 | 1.685 |
Fig. 7Morphological effect of extracts on zebrafish embryogenesis after 96 h of exposure (hpf). (A–B) 96 hpf embryo during control and non-toxic concentration exposure demonstrated straight spine, normal body shape, normal heartbeat, round yolk sac and high intensity of pigmentation on the body and eye. (C) 96 hpf embryos after exposed to teratogen concentration exhibited morphological defects such as bending spine, pericardial edema, enlarged yolk sac and hatching delayed. (D) Coagulated eggs with organ malformation after exposure to toxic concentration.
Fig. 8Correlation between LC50-96 hpf and IC50 of three tested cells. 1.1B4 displayed the closest relation between cytotoxicity and embryotoxicity with R2 = 0.3444. Linear regression indicated a correlation between LC50-96 hpf and IC50 with positive slope of 0.4620 and y-intercept at 0.6697.
Fig. 9Correlation between LC50-48 hpf and IC50 of three tested cells. Better relationships were observed between LC50-48 hpf and IC50 as compared to LC50-96 hpf and IC50 for 3T3-L1 cells and WRL-68. 3T3-L1 exhibited the highest correlation with LC50-48 hpf with R2 = 0.6077. The slope was 1.712 and y-intercept at 0.6064.